South Dakota Investment Council’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
10,119
+7,769
| +331% | +$4.08M | 0.1% | 189 |
|
|
2025
Q1 | $1.49M | Buy |
+2,350
| New | +$1.49M | 0.03% | 348 |
|
|
2023
Q3 | – | Sell |
-493
| Closed | -$354K | – | 628 |
|
|
2023
Q2 | $354K | Sell |
493
-100
| -17% | -$71.8K | 0.01% | 560 |
|
|
2023
Q1 | $487K | Hold |
593
| – | – | 0.01% | 537 |
|
|
2022
Q4 | $428K | Sell |
593
-101
| -15% | -$72.9K | 0.01% | 546 |
|
|
2022
Q3 | $478K | Hold |
694
| – | – | 0.01% | 527 |
|
|
2022
Q2 | $410K | Hold |
694
| – | – | 0.01% | 540 |
|
|
2022
Q1 | $485K | Sell |
694
-330
| -32% | -$231K | 0.01% | 518 |
|
|
2021
Q4 | $647K | Sell |
1,024
-800
| -44% | -$505K | 0.01% | 519 |
|
|
2021
Q3 | $1.1M | Hold |
1,824
| – | – | 0.02% | 450 |
|
|
2021
Q2 | $1.02M | Sell |
1,824
-650
| -26% | -$363K | 0.02% | 468 |
|
|
2021
Q1 | $1.17M | Sell |
2,474
-510
| -17% | -$241K | 0.02% | 461 |
|
|
2020
Q4 | $1.44M | Sell |
2,984
-300
| -9% | -$145K | 0.03% | 387 |
|
|
2020
Q3 | $1.84M | Sell |
3,284
-900
| -22% | -$504K | 0.04% | 321 |
|
|
2020
Q2 | $2.61M | Sell |
4,184
-450
| -10% | -$281K | 0.06% | 250 |
|
|
2020
Q1 | $2.26M | Sell |
4,634
-1,676
| -27% | -$818K | 0.06% | 240 |
|
|
2019
Q4 | $2.37M | Sell |
6,310
-320
| -5% | -$120K | 0.05% | 289 |
|
|
2019
Q3 | $1.84M | Buy |
6,630
+480
| +8% | +$133K | 0.04% | 358 |
|
|
2019
Q2 | $1.93M | Buy |
6,150
+2,275
| +59% | +$712K | 0.04% | 321 |
|
|
2019
Q1 | $1.59M | Buy |
3,875
+200
| +5% | +$82.1K | 0.03% | 356 |
|
|
2018
Q4 | $1.37M | Hold |
3,675
| – | – | 0.03% | 329 |
|
|
2018
Q3 | $1.49M | Sell |
3,675
-13,565
| -79% | -$5.48M | 0.03% | 357 |
|
|
2018
Q2 | $5.95M | Buy |
17,240
+13,940
| +422% | +$4.81M | 0.13% | 145 |
|
|
2018
Q1 | $1.14M | Buy |
+3,300
| New | +$1.14M | 0.03% | 402 |
|